Clin2
NCT07764692Possibly a fitNot yet recruiting

How itraconazole affects the new drug hs-10504

Healthy Participants

Treatments studied

This study tests how a medication called itraconazole affects the levels of a new drug called HS-10504 in your body. It aims to see if taking these together changes how the new drug is absorbed or processed, which helps decide safe dosing for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You need to agree to use highly effective birth control during the study and for 6 months after the last dose, and you must not plan to have children or donate sperm/eggs in that time.
  • You should be in generally good health, without serious conditions affecting your heart, lungs, stomach, kidneys, brain, or mental health.
  • You cannot have taken any other experimental drug or device in a clinical trial within the last 3 months.
  • You must not have taken any prescription or over-the-counter medications (including herbal supplements) in the last 30 days, except for topical skin products.
  • You must not smoke more than 5 cigarettes a day or use tobacco products during the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07535970Not yet recruiting· Phase 1
Drug interaction study in healthy adults

This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.

Jinan, Shandong
NCT07770217Not yet recruiting· Phase 1
Study of a new drug for healthy adults

This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.

NCT07775261Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine called Lu AH69593 in healthy people to see how safe it is and how the body handles it. Participants will stay at the clinic for a short time. This is an early-stage trial, so it may not directly help you, but it helps develop future treatments.

Madison, Wisconsin
NCT07373457Recruiting· Phase 1
Testing a new drug in healthy volunteers

This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.

Changchun
NCT07134465Enrolling by invitation· Phase 1
Drug interaction study of HSK31858 and itraconazole

This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.

Shanghai
NCT07685600Recruiting· Phase 1
Drug interaction study of AZD4144 and itraconazole

This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.

Harrow

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.